![Thomas Soloway](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Soloway
Direktor/Vorstandsmitglied bei
THIRD HARMONIC BIO, INC.
Profil
Thomas M.
Soloway was the founder of Transcept Pharma, Inc. (2002) and served as SVP, Chief Operating & Financial Officer from 2012 to 2013.
Current jobs include Chief Executive Officer at T-Knife GmbH since 2021, President & Chief Executive Officer at T-Knife Therapeutics, Inc., and Independent Director at Third Harmonic Bio, Inc. since 2022.
Former jobs include Director at Novacea, Inc. in 2009, Independent Director at Satsuma Pharmaceuticals, Inc. from 2020 to 2023, Principal at Montreux Equity Partners, Inc. from 1993 to 2002, Senior Vice President-Media at Ascendis Pharma A from 2015 to 2019, Chief Financial Officer, Treasurer & Senior VP at Astellas Gene Therapies, Inc. in 2020, and Chief Operating Officer at Paratek Pharmaceuticals, Inc. Education includes an undergraduate degree from the University of Southern California and an MBA from Georgetown University.
Aktive Positionen von Thomas Soloway
| Unternehmen | Position | Beginn |
|---|---|---|
| THIRD HARMONIC BIO, INC. | Direktor/Vorstandsmitglied | 01.07.2022 |
T-Knife GmbH
 T-Knife GmbH BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops novel therapeutics to fight cancer | Vorstandsvorsitzender | 19.01.2021 |
T-Knife Therapeutics, Inc.
 T-Knife Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that dedicated to developing novel therapeutics to fight cancer and provides T cell therapy services | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Thomas Soloway
| Unternehmen | Position | Ende |
|---|---|---|
| SATSUMA PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 08.06.2023 |
| AUDENTES THERAPEUTICS, INC. | Finanzdirektor/CFO | 01.09.2020 |
| ASCENDIS PHARMA A/S | Finanzdirektor/CFO | 01.09.2015 |
Transcept Pharma, Inc.
 Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Gründer | 01.12.2013 |
Novacea, Inc.
 Novacea, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Direktor/Vorstandsmitglied | 06.02.2009 |
Ausbildung von Thomas Soloway
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
54
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Montreux Equity Partners, Inc.
 Montreux Equity Partners, Inc. Investment ManagersFinance Montreux Equity Partners invests in companies located in the United States. The firm focuses on healthcare and financial technology sectors. It provides financing for seed, early and growth stage capital requirements with a revenue size of USD 5 - 50 million per company with an initial investment size of USD 10 - 20 million. | Finance |
Novacea, Inc.
Novacea, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Georgetown University
 Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ascendis Pharma A/S
 Ascendis Pharma A/S Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapies for metabolic, cardiovascular and ophthalmology | Health Technology |
Transcept Pharma, Inc.
Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes gene therapy products for patients with serious rare diseases | Health Technology |
Paratek Pharmaceuticals, Inc.
 Paratek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Satsuma Pharmaceuticals, Inc.
 Satsuma Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company for migraine and debilitating conditions | Health Technology |
T-Knife GmbH
T-Knife GmbH BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops novel therapeutics to fight cancer | Health Technology |
Third Harmonic Bio, Inc.
 Third Harmonic Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of allergic and immune diseases and disorders | Health Technology |
T-Knife Therapeutics, Inc.
T-Knife Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that dedicated to developing novel therapeutics to fight cancer and provides T cell therapy services | Health Technology |
